"The Future of Psychedelics" Investors Dinner Convenes in Boulder, Colorado

Presenting Top Leaders in the Psychedelics Industry

News provided by

Aug 10, 2021, 10:30 ET

BOULDER, Colo., Aug. 10, 2021 /PRNewswire/ -- "The Future of Psychedelics" Investors Dinner will take place Thursday, August 12th, 2021, featuring presentations by leaders in the emerging psychedelics industry. The sold-out event, hosted by The Huttner Group, Jade Green Consulting and Young America Capital will be held at the St. Julien Hotel in Boulder, CO.

The event is reserved for accredited investors interested in learning more about the companies leading the charge in the development of psychedelic businesses and technologies that many consider "the next frontier." The dinner will begin with a brief talk by drug policy reform expert Ethan Nadelmann, JD/Ph.D., founder and former executive director of the Drug Policy Alliance and one of the nation's greatest proponents of ending the failed War on Drugs.

"My team and I have built an extensive network of high-impact investors interested in psychedelics," says Michael Huttner, president of the Huttner Group. "The interest in our 'Future of Psychedelics' Investors Dinner has been overwhelming. Confirmed attendees include ultra-high-net-worth individuals and family offices from the U.S. and abroad, all of whom are traveling to Boulder to learn more about this exciting new industry and the opportunity to invest in businesses at the forefront of its growth."

According to Psy Market Research, psychedelics fundraising has significantly accelerated in recent months. Between September 2020 and January 2021 alone, psychedelics companies raised more than $550 million, and the total amount of capital raised industry-wide continues to trend upward.

"The Future of Psychedelics" Presenters:

AJNA BioSciences - A botanical drug development company focused on naturally derived compounds to target innovative new therapies for depression, addiction, PTSD, Alzheimer's and Parkinson's diseases.

aNUma - Creating breakthrough therapeutics by combining psychedelic science with group experiences in virtual reality. Led by experienced technology entrepreneurs and some of the world's top psychedelic practitioners and researchers, aNUma is raising seed capital to turn their data-backed proof-of-concept into a platform for delivering best-practice psychedelic preparation and integration at scale.

Psychedelic Water - The world's first commercially available, branded psychedelic blend with all-natural ingredients offering a mild, mood-boosting experience. The Water contains kava root, which originated in the South Pacific and has been used for centuries as a ritualistic drink brewed into a tea that provides an elevated and relaxing effect. Psychedelic Water is raising up to $7.5M as a pre-IPO offering to continue its growth.

Woven Science - A wellness platform building an ecosystem of companies in four key focus areas: compounds, clinics, community, and technology and a portfolio up more than 400% in two years since inception. Woven is raising a $7M bridge round to accelerate the next growth phase via a merger with a high-conviction drug development company before a combined Series A in Q4, 2021.

"We are thrilled to have an all-star line-up of speakers, presenters, and attendees for this exciting event," said Jade Green, founder and CEO of Jade Green Consulting. "The psychedelics space represents a new, high-growth opportunity for investors that will have a profound impact on people, the economy, and society as a whole," Green noted.

"The Future of Psychedelics" Investors Dinner is not a recommendation to buy or sell any securities. The event is limited to accredited and institutional investors. Request an invitation from Michael Huttner at [email protected].

Contact:
Leland Radovanovic
Conscious Communications Collective
845-200-5249
[email protected]

SOURCE Young America Capital